Related Experiment Video

Updated: Feb 24, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.7K

Current status and future direction in the management of malignant melanoma

Patrick Gladfelter1, Noureldien H E Darwish, Shaker A Mousa

  • 1aThe Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, New York, USA bDepartment of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

Melanoma Research
|August 12, 2017
PubMed

Insights

Metastatic melanoma is a deadly cancer with limited treatment options. Advances in genomic understanding are paving the way for personalized medicine, including targeted therapies and immunotherapies, to improve patient survival.

Area of Science:

  • Oncology
  • Genomics
  • Immunotherapy

Background:

  • Malignant melanoma incidence is rising globally.
  • Metastatic melanoma has a high mortality rate and limited treatment efficacy.
  • Current treatments like oncogene and immune-targeted strategies show variable overall survival benefits.

Purpose of the Study:

  • To review recent advances in cancer research for metastatic melanoma.
  • To explore the impact of molecular medicine and personalized approaches on melanoma treatment.
  • To discuss novel immunotherapeutic strategies for metastatic melanoma.

Main Methods:

  • Review of recent literature on molecular medicine and cancer genomics.
  • Analysis of current and emerging treatment strategies for metastatic melanoma.
  • Exploration of personalized medicine applications in cancer diagnosis, treatment selection, and monitoring.

Main Results:

  • Genomic understanding enables personalized cancer treatment.
  • Personalized medicine may revolutionize immunotherapeutic approaches.
  • Individualized cancer vaccines and adoptive T cell transfer are promising avenues.

Conclusions:

  • Personalized medicine offers a new paradigm for metastatic melanoma treatment.
  • Genomic insights are crucial for developing effective, individualized therapies.
  • Future treatment of metastatic melanoma will likely involve tailored immunotherapeutic strategies.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.6K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K